Estrogenic activity of two standardized red clover extracts (Menoflavon®) intended for large scale use in hormone replacement therapy

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 1, 2001, Pages 67-75

  Dornstauder, E ^a   Jisa, E ^a   Unterrieder, I ^a   Krenn, L ^a   Kubelka, W ^a   Jungbauer, A ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

Estrogen receptor and ; HRT; Red clover; Saccharomyces cerevisiae; Transactivation

Indexed keywords

6 METHOXYFLAVANON; BIOCHANIN A; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORMONONETIN; GENISTEIN; ISOFLAVONE DERIVATIVE; MENOFLAVON; PLANT EXTRACT; RED CLOVER EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOASSAY; CALCULATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG USE; ESTROGEN ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; MATHEMATICAL MODEL; NONHUMAN; PLANT; PLASMID; TRANSACTIVATION; YEAST;

BETA-GALACTOSIDASE; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; ESTROGENS, NON-STEROIDAL; GENES, REPORTER; HORMONE REPLACEMENT THERAPY; ISOFLAVONES; MODELS, CHEMICAL; PHYTOESTROGENS; PLANT EXTRACTS; PLANT PREPARATIONS; RECEPTORS, ESTROGEN; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATION (GENETICS); TWO-HYBRID SYSTEM TECHNIQUES;

SACCHAROMYCES CEREVISIAE; TRIFOLIUM PRATENSE;

EID: 0034872026     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00075-9     Document Type: Article

References (46)

1. The effects of oestrogen deficiency on the skeleton and its prevention
2. Factors associated with early menopause
3. Current perspectives on the benefits of HRT in menopausal women
4. 17 Beta-estradiol for postmenopausal estrogen replacement therapy
5. Post-menopausal osteoporosis and estrogens. Who should be treated and why
6. Use of HRT and the subsequent risk of cancer
7. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies
8. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy
9. Update on cancer control in women
10. The postmenopausal estrogen/breast cancer controversy
11. Commonly occurring plant flavonoids have estrogenic activity
12. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor
13. Monitoring of estrogen mimics by a recombinant yeast assay: Synergy between natural and synthetic compounds?
14. A specific breeding problem of sheep on subterranean clover pastures in Western Australia
15. Phytoestrogens: The 'natural' selective estrogen receptor modulators?
16. Phytoestrogen content of foods - A compendium of literature values
17. Estrogen and progestin bioactivity of foods, herbs, and spices
18. Bioavailability of soybean isoflavones depends upon gut microflora in women
19. A review of the clinical effects of phytoestrogens
20. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells
21. Clinical review 97: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence
22. Exposure of infants to phyto-oestrogens from soy-based infant formula
23. Dietary isoflavones: Biological effects and relevance to human health
24. Soy protein, isoflavones and cardiovascular disease risk
25. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids
26. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells
27. Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice
28. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
29. Antioxidant and antipromotional effects of the soybean isoflavone genistein
30. Antioxidant activity of phytoestrogenic isoflavones
31. Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor beta signaling pathways
32. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo
33. Growth inhibition of human breast cancer cells by herbs and phytoestrogens
34. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques
35. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists
36. Ubiquitin-metallothionein fusion protein expression in yeast
37. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli
38. Agonistic and synergistic activity of tamoxifen in a yeast model system
39. An intracellular expression system for yeast using ubiquitin-Flag-fusions
40. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
41. Regulation of human estrogen receptor by phytoestrogens in yeast and human cells
42. Phytoestrogens and cardiovascular health
43. Phytoestrogens and the management of menopause
44. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist